BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16691463)

  • 1. Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group-based modeling approach.
    Xie H; Drake R; McHugo G
    Adm Policy Ment Health; 2006 Jul; 33(4):423-32. PubMed ID: 16691463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytic methods for modeling longitudinal data from rolling therapy groups with membership turnover.
    Morgan-Lopez AA; Fals-Stewart W
    J Consult Clin Psychol; 2007 Aug; 75(4):580-93. PubMed ID: 17663612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental health and substance abuse services to parents of children involved with child welfare: a study of racial and ethnic differences for American Indian parents.
    Libby AM; Orton HD; Barth RP; Webb MB; Burns BJ; Wood PA; Spicer P
    Adm Policy Ment Health; 2007 Mar; 34(2):150-9. PubMed ID: 17066330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group intervention for coexisting psychosis and substance use disorders in rural Australia: outcomes over 3 years.
    Bradley AC; Baker A; Lewin TJ
    Aust N Z J Psychiatry; 2007 Jun; 41(6):501-8. PubMed ID: 17508320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of drug abuse treatment: relevant issues and alternative longitudinal modeling approaches.
    Hser YI; Anglin MD
    NIDA Res Monogr; 1991; 113():67-93. PubMed ID: 1762644
    [No Abstract]   [Full Text] [Related]  

  • 8. Combining group-based trajectory modeling and propensity score matching for causal inferences in nonexperimental longitudinal data.
    Haviland A; Nagin DS; Rosenbaum PR; Tremblay RE
    Dev Psychol; 2008 Mar; 44(2):422-36. PubMed ID: 18331133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of statistical models to predict mental health and substance abuse cost.
    Montez-Rath M; Christiansen CL; Ettner SL; Loveland S; Rosen AK
    BMC Med Res Methodol; 2006 Oct; 6():53. PubMed ID: 17067394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First person accounts of long-term employment activity among people with dual diagnosis.
    Strickler DC; Whitley R; Becker DR; Drake RE
    Psychiatr Rehabil J; 2009; 32(4):261-8. PubMed ID: 19346204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider-level effects on psychiatric inpatient length of stay for youth with mental health and substance abuse disorders.
    Gifford E; Foster EM
    Med Care; 2008 Mar; 46(3):240-6. PubMed ID: 18388838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of publicly funded managed care on adolescent substance abuse treatment outcomes.
    Harrow BS; Tompkins CP; Mitchell PD; Smith KW; Soldz S; Kasten L; Fleming K
    Am J Drug Alcohol Abuse; 2006; 32(3):379-98. PubMed ID: 16864469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ecology of adolescent substance abuse service utilization.
    Jones DL; Heflinger CA; Saunders RC
    Am J Community Psychol; 2007 Dec; 40(3-4):345-58. PubMed ID: 17906925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Income and employment of people living with combined HIV/AIDS, chronic mental illness, and substance abuse disorders.
    Conover CJ; Arno P; Weaver M; Ang A; Ettner SL
    J Ment Health Policy Econ; 2006 Jun; 9(2):71-86. PubMed ID: 17007485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based study on substance abuse treatment for adults with disabilities: access, utilization, and treatment outcomes.
    Krahn G; Deck D; Gabriel R; Farrell N
    Am J Drug Alcohol Abuse; 2007; 33(6):791-8. PubMed ID: 17994475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance use disorder among older adults in the United States in 2020.
    Han B; Gfroerer JC; Colliver JD; Penne MA
    Addiction; 2009 Jan; 104(1):88-96. PubMed ID: 19133892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propensity score estimation with boosted regression for evaluating causal effects in observational studies.
    McCaffrey DF; Ridgeway G; Morral AR
    Psychol Methods; 2004 Dec; 9(4):403-25. PubMed ID: 15598095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental trajectories of depressive symptoms from early childhood to late adolescence: gender differences and adult outcome.
    Dekker MC; Ferdinand RF; van Lang ND; Bongers IL; van der Ende J; Verhulst FC
    J Child Psychol Psychiatry; 2007 Jul; 48(7):657-66. PubMed ID: 17593146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.